Preferred Name |
Nalbuphine Hydrochloride |
|
Synonyms |
|
|
Definitions |
The hydrochloride salt form of nalbuphine, a synthetic phenanthrene opioid with opiate agonist and antagonist effects, used to treat moderate to severe pain and provide preoperative and postoperative analgesia and sedation. Nalbuphine hydrochloride binds to kappa-, mu- and delta-opioid receptors but not to sigma-opioid receptors. This opioid exerts its analgesic actions primarily through kappa-opioid-receptor agonism and partially through mu-opioid receptor agonism. |
|
ID |
http://purl.obolibrary.org/obo/NCIT_C47629 |
|
CAS_Registry |
23277-43-2 |
|
CHEBI_ID |
CHEBI:7455 |
|
Chemical_Formula |
C21H27NO4.HCl |
|
code |
C47629 |
|
Contributing_Source |
FDA |
|
definition |
The hydrochloride salt form of nalbuphine, a synthetic phenanthrene opioid with opiate agonist and antagonist effects, used to treat moderate to severe pain and provide preoperative and postoperative analgesia and sedation. Nalbuphine hydrochloride binds to kappa-, mu- and delta-opioid receptors but not to sigma-opioid receptors. This opioid exerts its analgesic actions primarily through kappa-opioid-receptor agonism and partially through mu-opioid receptor agonism. |
|
FDA_UNII_Code |
ZU4275277R |
|
Has_Free_Acid_Or_Base_Form | ||
in_subset | ||
label |
Nalbuphine Hydrochloride |
|
Legacy Concept Name |
Nalbuphine_Hydrochloride |
|
Preferred_Name |
Nalbuphine Hydrochloride |
|
prefixIRI |
NCIT:C47629 |
|
prefLabel |
Nalbuphine Hydrochloride |
|
Semantic_Type |
Pharmacologic Substance |
|
UMLS_CUI |
C0600099 |
|
subClassOf |